Australia recalls Abbott’s bioresorbable heart stent
Australian officials recalled Abbott Vascular’s Absorb Bioresorbable Vascular Scaffold System after research linked it to elevated rates of heart attack and blood clots, reports the Daily Mail.
The scaffold is designed to open blocked coronary arteries and then fully dissolve in the body. Since being recalled in Australia, it has been removed from the Australian Register of Therapeutic Goods.
Officials recommend that patients who already have the Absorb stent should see their doctors to ensure they are receiving appropriate treatment.
To read the full article, follow the link below.
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.